NO875359L - Fremgangsmaate for fremstilling av farmasoeytiske preparater - Google Patents

Fremgangsmaate for fremstilling av farmasoeytiske preparater

Info

Publication number
NO875359L
NO875359L NO875359A NO875359A NO875359L NO 875359 L NO875359 L NO 875359L NO 875359 A NO875359 A NO 875359A NO 875359 A NO875359 A NO 875359A NO 875359 L NO875359 L NO 875359L
Authority
NO
Norway
Prior art keywords
procedure
preparation
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
NO875359A
Other languages
English (en)
Other versions
NO875359D0 (no
Inventor
A R Clark
P Wright
J H Ratcliffe
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630769A external-priority patent/GB8630769D0/en
Priority claimed from GB868630767A external-priority patent/GB8630767D0/en
Priority claimed from GB868630904A external-priority patent/GB8630904D0/en
Priority claimed from GB878706684A external-priority patent/GB8706684D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of NO875359D0 publication Critical patent/NO875359D0/no
Publication of NO875359L publication Critical patent/NO875359L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO875359A 1986-12-23 1987-12-21 Fremgangsmaate for fremstilling av farmasoeytiske preparater NO875359L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868630769A GB8630769D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630767A GB8630767D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630904A GB8630904D0 (en) 1986-12-24 1986-12-24 Pharmaceutical formulation
GB878706684A GB8706684D0 (en) 1987-03-20 1987-03-20 Pharmaceutical formulation

Publications (2)

Publication Number Publication Date
NO875359D0 NO875359D0 (no) 1987-12-21
NO875359L true NO875359L (no) 1988-06-24

Family

ID=27449862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875359A NO875359L (no) 1986-12-23 1987-12-21 Fremgangsmaate for fremstilling av farmasoeytiske preparater

Country Status (22)

Country Link
US (1) US5443833A (no)
EP (1) EP0279121B1 (no)
JP (2) JP2568233B2 (no)
KR (1) KR960001370B1 (no)
AU (1) AU595969B2 (no)
BE (2) BE1002179A5 (no)
CA (1) CA1296635C (no)
CH (1) CH674937A5 (no)
DE (1) DE3787274T2 (no)
DK (1) DK175032B1 (no)
ES (1) ES2058129T3 (no)
FI (1) FI875616A (no)
FR (1) FR2609392B1 (no)
GR (1) GR871999B (no)
IE (3) IE940372L (no)
IL (1) IL84893A (no)
LU (1) LU87087A1 (no)
MY (1) MY101535A (no)
NO (1) NO875359L (no)
NZ (1) NZ223026A (no)
PT (1) PT86455B (no)
SA (1) SA90110074B1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
CA2781923C (en) * 2009-12-03 2018-08-14 Opko Health, Inc. Hypersulfated disaccharide formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
ATE11774T1 (de) * 1979-12-07 1985-02-15 Fisons Plc Verfahren zur herstellung von 1,4-dihydro-4-oxo- chinolin-2-carbonsaeuren oder salzen, estern oder amiden davon und zwischenverbindungen dafuer.
AU8468782A (en) * 1981-06-25 1983-01-06 Fisons Plc Compounds with sodium cromoglycate activity
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
DE3584580D1 (de) * 1984-04-13 1991-12-12 Fisons Plc Formen und formulierungen des nedocromil-natriumsalzes.
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
GB2202145B (en) * 1987-03-17 1991-01-02 Fisons Plc Compositions of nedocromil for dermatological use.

Also Published As

Publication number Publication date
DK680787D0 (da) 1987-12-22
LU87087A1 (fr) 1989-07-07
FI875616A0 (fi) 1987-12-21
KR960001370B1 (ko) 1996-01-26
IL84893A0 (en) 1988-06-30
IE940371L (en) 1988-06-23
JPS63233918A (ja) 1988-09-29
US5443833A (en) 1995-08-22
FI875616A (fi) 1988-06-24
CA1296635C (en) 1992-03-03
CH674937A5 (no) 1990-08-15
EP0279121A2 (en) 1988-08-24
AU595969B2 (en) 1990-04-12
DK680787A (da) 1988-06-24
AU8292987A (en) 1988-06-23
JP2568233B2 (ja) 1996-12-25
EP0279121B1 (en) 1993-09-01
PT86455A (en) 1988-01-01
JP2504926B2 (ja) 1996-06-05
GR871999B (en) 1988-04-26
PT86455B (pt) 1990-11-20
SA90110074B1 (ar) 2006-03-06
EP0279121A3 (en) 1990-09-12
DK175032B1 (da) 2004-05-03
IE63213B1 (en) 1995-04-05
BE1003466A3 (fr) 1992-03-31
DE3787274D1 (de) 1993-10-07
BE1002179A5 (fr) 1990-10-02
DE3787274T2 (de) 1994-01-27
JPH07231926A (ja) 1995-09-05
MY101535A (en) 1991-11-30
IE873507L (en) 1988-06-23
KR880007082A (ko) 1988-08-26
NZ223026A (en) 1989-09-27
FR2609392A1 (fr) 1988-07-15
FR2609392B1 (fr) 1994-04-08
IE940372L (en) 1988-06-23
NO875359D0 (no) 1987-12-21
IL84893A (en) 1991-11-21
ES2058129T3 (es) 1994-11-01

Similar Documents

Publication Publication Date Title
NO872966L (no) Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NO171006C (no) Fremgangsmaate for fremstilling av antioksyderende preparater
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK413987D0 (da) Farmaceutiske praeparater
ES550808A0 (es) Procedimiento de obtencion de preparados farmaceuticos de liberacion gradual prolongada
NO862141L (no) Fremgangsmaate for fremstilling av aktive cinnolinderivater
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO173604C (no) Analogifremgangsmaate til fremstilling av bis-dioksopiperazinderivater
DK652787A (da) Farmaceutiske praeparater
NO874200D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO873423D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO875359D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
DK447887A (da) Frysetoerrede farmaceutiske praeparater
NO174085C (no) Fremgangsmåte for fremstilling av sukralfatpreparater
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO874539L (no) Fremgangsmaate for fremstilling av nye farmasoeytiske preparater.
NO872683D0 (no) Fremgangsmaate for fremstilling av difenylazometinderivater